Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis

par Takahashi M, Flynn JA, Tanji Y, Ascher-Svanum H, Ye W, Conley RR
Publié 2012

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

par Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H
Publié 2014

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

par Ascher-Svanum H, Brnabic AJM, Lawson AH, Kinon BJ, Stauffer VL, Feldman PD, Kelin K
Publié 2012

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia

par Chen L, Ascher-Svanum H, Lawson A, Stauffer VL, Nyhuis A, Haynes V, Schuh K, Kinon BJ
Publié 2013

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

par Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensl, MD, Ascher-Svanum H
Publié 2014